RICHMOND, BRITISH COLUMBIA--(CCNMatthews - March 7, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV), a medical devices company specializing in products for the vascular and surgical markets, has received physician feedback from its Metricath Gemini® dual-balloon angioplasty device clinical trial.
